13F filer · CIK 1595851
Ghost Tree Capital, LLC
NEW YORK, NY · filing since Q4 2013 · last filing Nov 14, 2024
Reported value
$331.0M
+$11.7M vs prior
Positions
54
New / sold out
12 / 21
Added / reduced
16 / 23
Turnover
38.8%
buys $126.2M · sells $146.4M
Top-10 weight
42.4%
Biggest buys vs Q2 2024
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | SPDR SER TRPUT | +300,000 | – | +$29.6M |
| New | BIOHAVEN LTD | +348,778 | – | +$17.4M |
| New | NOVO-NORDISK A S | +110,000 | – | +$13.1M |
| Added | BLUEPRINT MEDICINES CORP | +100,000 | +250.0% | +$9.3M |
| Added | SAREPTA THERAPEUTICS INC | +65,000 | +118.2% | +$8.1M |
| Added | JANUX THERAPEUTICS INC | +140,000 | +280.0% | +$6.4M |
| New | EDGEWISE THERAPEUTICS INC | +195,000 | – | +$5.2M |
| New | CORBUS PHARMACEUTICALS HLDGSPUT | +220,000 | – | +$4.5M |
| Added | TARSUS PHARMACEUTICALS INC | +115,000 | +48.9% | +$3.8M |
| New | DYNE THERAPEUTICS INC | +100,000 | – | +$3.6M |
18 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest sells vs Q2 2024
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | BIOHAVEN LTD | -490,000 | -100.0% | $-17.0M |
| Sold out | ALNYLAM PHARMACEUTICALS INCPUT | -68,400 | -100.0% | $-16.6M |
| Reduced | VIRIDIAN THERAPEUTICS INC | -512,708 | -87.2% | $-11.7M |
| Reduced | INSMED INCCALL | -150,000 | -75.0% | $-10.9M |
| Reduced | MOONLAKE IMMUNOTHERAPEUTICS | -171,589 | -57.2% | $-8.7M |
| Reduced | VAXCYTE INC | -70,000 | -46.7% | $-8.0M |
| Reduced | SOLENO THERAPEUTICS INC | -150,000 | -50.0% | $-7.6M |
| Reduced | SPYRE THERAPEUTICS INC | -190,237 | -76.0% | $-5.6M |
| Sold out | ALNYLAM PHARMACEUTICALS INC | -22,500 | -100.0% | $-5.5M |
| Reduced | ASCENDIS PHARMA A/S | -34,221 | -39.5% | $-5.1M |
34 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q3 2024
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | SPDR SER TRPUTS&P BIOTECH | 300,000 | $29.6M | 8.95% |
| 2 | BIOHAVEN LTDCALL | 348,778 | $17.4M | 5.26% |
| 3 | SAREPTA THERAPEUTICS INCCOM | 120,000 | $15.0M | 4.53% |
| 4 | NOVO-NORDISK A SADR | 110,000 | $13.1M | 3.96% |
| 5 | BLUEPRINT MEDICINES CORPCOM | 140,000 | $12.9M | 3.91% |
| 6 | AXSOME THERAPEUTICS INCCOM | 135,000 | $12.1M | 3.66% |
| 7 | TARSUS PHARMACEUTICALS INCCOM | 350,000 | $11.5M | 3.48% |
| 8 | PERSPECTIVE THERAPEUTICS INCCOM NEW | 750,000 | $10.0M | 3.02% |
| 9 | CG ONCOLOGY INCCOM | 250,000 | $9.4M | 2.85% |
| 10 | ROIVANT SCIENCES LTDSHS | 800,000 | $9.2M | 2.79% |
44 more rows. Subscribe for $29/month to see every row, download the data and use the API.